参考文献/References:
[1]De Santis GC,Brunetta DM,Nardo M,et al.Preoperative variables associated with transfusion requirements in orthotopic liver transplantation[J].TransfusApherSci,2014,50(1):99-105.
[2]赵玲莉,耿惠,邓丽君,等.EPO的临床研究进展[J].青海医药杂志,2011,41(3):74-77.
[3]张亚芳.促红细胞生成素在危重患者贫血治疗中的效果及安全性探讨[J].华夏医学,2013,26(3):492-494.
[4]姚泰.生理学[M].第6版.北京:人民卫生出版社,2004:53.[5]Posluszny Jr JA,Napolitano LM.How do we treat life-threatening anemia in a Jehovah's Witness patient[J].Transfusion,2014,54(12):3026-3034.
[6]Garcia JH,Coelho GR,FeitosaNeto BA,et al.Liver transplantation in Jehovah's Witnesses patients in a center of northeastern Brazil[J].ArqGastroenterol,2013,50(2):138-140.
[7]de Araujo Azi LM,Lopes FM,Garcia LV.Postoperative management of severe acute anemia in a Jehovah's Witness[J].Transfusion,2014,54(4):1153-1157.
[8]Brunetta DM,Kaufman J,DeSantis GC,et al.Severe Acute Anemia After Liver Transplantation in an Elderly Jehovah's Witness Treated With High-dose Erythropoietin and Ferric Carboxymaltose:A Case Report[J].Transplant Proc,2015,47(8):2548-2551.
[9]虞德明,白亚强,刘文晶.促红细胞生成素在开颅动脉瘤夹闭术后脑缺血中的应用效果[J].重庆医学,2017,46(3):394-396.
[10]朱栩宏,姜飞,杨晶,等.重组人促红细胞生成素及硫酸亚铁在Rh阴性骨盆骨折患者手术中的临床应用价值[J].中华实用诊断与治疗杂志,2017,31(3):284-286.
[11]Weltert L,Rondinelli B,Bello R,et al.A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial[J].Transfusion,2015,55(7):1644-1654.
[12]朱孔娟,袁莉,董河,等.EPO对脊柱外科病人围术期异体血需求和凝血功能的影响[J].青岛大学医学院学报,2015,51(5):517-520.
[13]宋作艳,袁莉,王世端,等.联合应用铁剂和促红细胞生成素对妇科贫血患者异体血需求的影响[J].解放军医学院学报,2014,35(4):316-318.
[14]Lund A,Lundby C,Olsen NV.High-dose erythropoietin for tissue protection[J].Eur J Clin Invest, 2014,44(12):1230-1238.
[15]Nangaku M.Tissue protection by erythropoietin:new findings in a moving field[J].Kidney Int ,2013,84(3):427-429.
[16]Greif F,Ben-Ari Z,Taya R,et al.Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats[J].Liver Transpl,2010,16(5):631-638.
[17]Shander A,Javidroozi M,Naqvi S,et al.An update on mortality and morbidity in patients with very low postoperative hemoglobin levels who decline blood transfusion(CME)[J].Transfusion ,2014,54(10):2688-2695.
[18]Fischer JW.Landmark advances in development of erythropoietin[J].ExpBiolMed,2010,235(12):1398-1411.
相似文献/References:
[1]张运昊.重组人促红细胞生成素治疗胃肠道恶性肿瘤化疗相关性贫血的疗效观察[J].医学信息,2019,32(08):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
ZHANG Yun-hao.Therapeutic Effect of Recombinant Human Erythropoietin on Chemotherapy-associated Anemia of Gastrointestinal Malignant Tumor[J].Journal of Medical Information,2019,32(05):151.[doi:10.3969/j.issn.1006-1959.2019.08.046]
[2]张 明,刘子荣,李 妍.肝移植患者术后自我管理现状与影响因素分析[J].医学信息,2019,32(14):138.[doi:10.3969/j.issn.1006-1959.2019.14.044]
ZHANG Ming,LIU Zi-rong,LI yan.Analysis of Self-management Status and Influencing Factors of
Postoperative Liver Transplantation Patients[J].Journal of Medical Information,2019,32(05):138.[doi:10.3969/j.issn.1006-1959.2019.14.044]
[3]顾义娟.待肝期精准健康教育对肝癌肝移植患者健康信念及负性情绪的影响[J].医学信息,2020,33(20):170.[doi:10.3969/j.issn.1006-1959.2020.20.054]
GU Yi-juan.The Impact of Precision Health Education on the Health Beliefs and Negative Emotions of Liver Cancer Patients Undergoing Liver Transplantation[J].Journal of Medical Information,2020,33(05):170.[doi:10.3969/j.issn.1006-1959.2020.20.054]